Eurofins Genomics launches EXTREmers
EXTREmer oligonucleotides are extremely long oligos developed using high-fidelity synthesis chemistry on the company's new DNA synthesis platform.
According to the company, the new service will be helpful for generating oligos for DNA-directed RNA interference, capture probes, or control standards in qPCR experiments, among other applications.
“Oligos are used routinely in genetic studies to make effective and specific modifications in various genes,” Sanjay Singh, technical marketing and product manager, Eurofins Genomics, told us.
“Biotech and pharmaceutical firms use these custom made DNA oligos of different lengths to make advances towards the discovery of better drugs or high-performing crops,” he added.
Singh explained EXTREmers, as well as the company’s regular oligos, help scientists “advance their specific goals efficiently.”
Jeff Nelson, head of process development for high-throughput synthesis at the company, also told us the new offering saves time, effort, and resources for researchers.
“Additional benefits include the ability to generate oligos in low quantities and significantly reduce the effort required to construct genes,” he added. “In summary, researchers can synthesize more complex ‘designer’ genes with less effort and a higher chance of success using EXTREmers.”
